Physician profile
Peter Barnard
NPI 1710993753
$997.84
in general payments reported to CMS, 2019-2025
20 companies · $413 in 2025
The $413 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $170 · 2023: $184 · 2024: $232 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $160.39 | 2022-2025 | |
| Astellas Pharma US INC | $121.81 | 2023-2024 | Veozah, Myrbetriq |
| Organon LLC | $84.23 | 2022-2025 | Nexplanon, Jada System |
| Biogen, INC. | $70.40 | 2024-2025 | Zurzuvae |
| Innovation Technologies INC | $68.54 | 2024-2025 | Irrisept |
| Baxter Healthcare | $66.49 | 2023-2025 | Perclot, Adept |
| Ethicon US, LLC | $65.83 | 2022-2025 | Vistaseal |
| Hologic Sales and Service, LLC | $63.47 | 2022-2025 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $56.84 | 2022-2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $44.02 | 2023-2024 | |
| Coloplast Corp | $33.55 | 2025 | |
| Exeltis, USA INC. | $32.82 | 2023-2024 | Slynd |
| Dexcom, INC. | $21.43 | 2025 | Dexcom G6 Transmitter |
| Axonics, INC. | $18.57 | 2024 | Bulkamid |
| Medtronic, INC. | $18.43 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.14 | 2025 | |
| Shield Therapeutics INC | $14.24 | 2025 | |
| Exact Sciences Corporation | $14.19 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $12.62 | 2022 | |
| Scynexis, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Barnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.